Background:
Chronic hepatitis B virus (HBV) infection is considered a risk factor for severe SARS-CoV-2 infection (COVID-19); however, there is conflicting evidence regarding its impact on COVID-19 outcomes in dually infected individuals. Furthermore, while COVID-19 vaccination has been associated with a lower risk of death and adverse outcomes in the general population, its effect on COVID-19 outcomes in individuals with chronic HBV infection remains unexplored.
Methods:
We used the TriNetX database to compare adult patients with confirmed SARS-CoV-2 infection and chronic HBV (COVID-HBV) and without chronic HBV (COVID-wo-HBV) who sought care across 77 healthcare systems in the United States from January 2020 to August 2023. We included people with HBV diagnosis codes and laboratory testing. We assessed the risk of inpatient hospitalization, intensive care unit admission, mechanical ventilation, early (30-day) and late (90-day) mortality. We further assessed the impact of COVID-19 vaccination on outcomes in subgroup analysis of COVID-HBV. We addressed potential confounders using 1:1 propensity score matching by demographics, key comorbidities, and COVID-19 vaccination. For outcomes of interest, we calculated odds ratios (OR) and 95% confidence intervals (CI), with statistical significance set at p < 0.05.
Results:
Of 3,360,173 individuals with confirmed SARS-CoV-2, about 0.2% (7,163) were COVID-HBV, of which 13.9% (996) were vaccinated. People with COVID-HBV had higher odds of 90-day mortality (OR 1.21, 95% CI 1.02-1.44; p = 0.032) and ICU admission (OR 1.39, 95% CI 1.17-1.66; p < 0.001) compared with COVID-wo-HBV; however, there was no significant difference between groups in 30-day mortality, hospitalization, and mechanical ventilation rates. In subgroup analysis of COVID-HBV, those who received COVID-19 vaccination had lower odds of death at 30 days (OR 0.38, 95% CI 0.22-0.66; p < 0.001) and 90 days (OR 0.46, 95% CI 0.31-0.70; p < 0.001). Vaccination was not associated with decreased odds of hospitalization, ICU admission, and mechanical ventilation rates.
Conclusions:
In the largest study to date, chronic HBV infection conferred higher odds of death and adverse outcomes in COVID-19. Notably, COVID-19 vaccination was associated with a significant reduction in the odds of death and the need for ICU admission, suggesting that vaccination could be an effective strategy for mitigating the impact of COVID-19 in individuals with chronic HBV infection.
![]()